Cellograph: a semi-supervised approach to analyzing multi-condition single-cell RNA-sequencing data using graph neural networks by Jamshaid A. Shahir, Natalie Stanley, Jeremy E. Purvis

Get full text

Patients’ quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, earl... by S. Tolaney, I. Blancas, Y.-H. Im, P. Rastogi, J. Brown, A. Shahir, A. Zimmermann, F. Boyle

Get full text

Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer by H. Rugo, J. O’Shaughnessy, C. Song, R. Broom, M. Gumus, T. Yamashita, B. San Antonio, A. Shahir, A. Zimmermann, F. Zagouri, M. Reinisch

Get full text

P017 Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4... by S. Johnston, M. Toi, J. O’Shaughnessy, P. Rastogi, M. Campone, P. Neven, C.S. Huang, J. Huober, G. Garnica Jaliffe, I. Cicin, S. Tolaney, M.P. Goetz, H. Rugo, E. Senkus, L. Testa, L. Del Mastro, C. Shimizu, R. Wei, A. Shahir, M. Munoz, B. San Antonio, V. Andre, N. Harbeck, M. Martín

Get full text